Hyaluronic Acid Improves the Tolerability of Hypertonic Saline in the Chronic Treatment of Cystic Fibrosis Patients: A Multicenter, Randomized, Controlled Clinical Trial

Abstract Trial Design and Methods: Between December 2009 and July 2011, four cystic fibrosis (CF) centers in Italy participated in a randomized, double-blind, controlled clinical trial to test whether 7% hypertonic saline (HS) administered together with 0.1% hyaluronic acid (HA) was better tolerated...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of aerosol medicine Ročník 27; číslo 2; s. 133 - 137
Hlavní autoři:	Ros, Mirco, Casciaro, Rosaria, Lucca, Francesca, Troiani, Patrizia, Salonini, Elena, Favilli, Federica, Quattrucci, Serena, Sher, Daniel, Assael, Baroukh Maurice
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Los Angeles, CA SAGE Publications 01.04.2014 Mary Ann Liebert, Inc
Témata:	Administration, Inhalation Adolescent Child Cough - chemically induced Cystic Fibrosis - diagnosis Cystic Fibrosis - drug therapy Cystic Fibrosis - physiopathology Double-Blind Method Drug Administration Schedule Female Forced Expiratory Volume Humans Hyaluronic Acid - administration & dosage Hyaluronic Acid - adverse effects Italy Lung - drug effects Lung - physiopathology Male Patient Compliance Saline Solution, Hypertonic - administration & dosage Saline Solution, Hypertonic - adverse effects Taste Time Factors Treatment Outcome Young Adult Italy clinical trial inhaled therapy cystic fibrosis hypertonic saline hyaluronan
ISSN:	1941-2711, 1941-2703, 1941-2703
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!